Reid Merryman, Md
Clinical trials sponsored by Reid Merryman, Md, explained in plain language.
-
New drug duo aims to tackle lymphoma without chemo
Disease control Recruiting nowThis study is testing whether a combination of two drugs, epcoritamab and rituximab, can effectively treat follicular lymphoma in people who have not had any prior treatment. The trial will enroll about 100 adults with CD20-positive follicular lymphoma. The goal is to see how man…
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New cocktail aims to beat back lymphoma when other treatments fail
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—epcoritamab, zanubrutinib, and rituximab—in 45 people with follicular or marginal zone lymphoma that has come back or not responded to prior treatment. The goal is to see how well the combo shrinks tumors and how safe it …
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC